Parker JD - Search Results

1

Renal handling of endothelin in patients with chronic heart failure.

Al-Hesayen A, Parker JD. Al-Hesayen A, et al. Among authors: parker jd. Am J Cardiol. 2005 Feb 15;95(4):532-4. doi: 10.1016/j.amjcard.2004.10.027. Am J Cardiol. 2005. PMID: 15695148

2

Digoxin reduces cardiac sympathetic activity in severe congestive heart failure.

Newton GE, Tong JH, Schofield AM, Baines AD, Floras JS, Parker JD. Newton GE, et al. Among authors: parker jd. J Am Coll Cardiol. 1996 Jul;28(1):155-61. doi: 10.1016/0735-1097(96)00120-9. J Am Coll Cardiol. 1996. PMID: 8752808 Free article.

3

Cardiac sympathetic responses to acute vasodilation. Normal ventricular function versus congestive heart failure.

Newton GE, Parker JD. Newton GE, et al. Among authors: parker jd. Circulation. 1996 Dec 15;94(12):3161-7. doi: 10.1161/01.cir.94.12.3161. Circulation. 1996. PMID: 8989124

4

Therapy with nitroglycerin increases coronary vasoconstriction in response to acetylcholine.

Caramori PR, Adelman AG, Azevedo ER, Newton GE, Parker AB, Parker JD. Caramori PR, et al. Among authors: parker jd, parker ab. J Am Coll Cardiol. 1998 Dec;32(7):1969-74. doi: 10.1016/s0735-1097(98)00456-2. J Am Coll Cardiol. 1998. PMID: 9857880 Free article. Clinical Trial.

5

Cardiac and systemic sympathetic activity in response to clonidine in human heart failure.

Azevedo ER, Newton GE, Parker JD. Azevedo ER, et al. Among authors: parker jd. J Am Coll Cardiol. 1999 Jan;33(1):186-91. doi: 10.1016/s0735-1097(98)00524-5. J Am Coll Cardiol. 1999. PMID: 9935028 Free article.

6

ARCTIC: assessment of haemodynamic response in patients with congestive heart failure to telmisartan: a multicentre dose-ranging study in Canada.

Parker AB, Azevedo ER, Baird MG, Smith SJ, Arnold JM, Humen DP, Moe GW, Parker JO, Butt RW, Parker JD. Parker AB, et al. Among authors: parker jd, parker jo. Am Heart J. 1999 Nov;138(5 Pt 1):843-8. doi: 10.1016/s0002-8703(99)70008-6. Am Heart J. 1999. PMID: 10539814 Clinical Trial.

7

Sympathetic responses to atrial natriuretic peptide in patients with congestive heart failure.

Azevedo ER, Newton GE, Parker AB, Floras JS, Parker JD. Azevedo ER, et al. Among authors: parker jd, parker ab. J Cardiovasc Pharmacol. 2000 Jan;35(1):129-35. doi: 10.1097/00005344-200001000-00017. J Cardiovasc Pharmacol. 2000. PMID: 10630743 Clinical Trial.

8

Reducing cardiac filling pressure lowers norepinephrine spillover in patients with chronic heart failure.

Azevedo ER, Newton GE, Floras JS, Parker JD. Azevedo ER, et al. Among authors: parker jd. Circulation. 2000 May 2;101(17):2053-9. doi: 10.1161/01.cir.101.17.2053. Circulation. 2000. PMID: 10790346

9

Nitroglycerin withdrawal increases endothelium-dependent vasomotor response to acetylcholine.

Azevedo ER, Schofield AM, Kelly S, Parker JD. Azevedo ER, et al. Among authors: parker jd. J Am Coll Cardiol. 2001 Feb;37(2):505-9. doi: 10.1016/s0735-1097(00)01140-2. J Am Coll Cardiol. 2001. PMID: 11216970 Free article. Clinical Trial.

10

Increased extraction of endothelin-1 across the failing human heart.

Azevedo ER, Stewart DJ, Parker JD. Azevedo ER, et al. Among authors: parker jd. Am J Cardiol. 2001 Jul 15;88(2):180-2, A6. doi: 10.1016/s0002-9149(01)01618-6. Am J Cardiol. 2001. PMID: 11448420

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

547 results

Search Page

Filters